Global Cardiology Academy

Welcome to Global
Cardiology Academy

Enhance your cardiology practice with CME and
tools focused on heart health management.

Tirzepatide reduces HF events in patients with HFpEF and obesity
Tirzepatide reduces HF events in patients with HFpEF and obesity
Heart Matters
Tirzepatide reduces HF events in patients with HFpEF and obesity
- Milton Packer, MD
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
Heart Matters
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
- Shawna Nesbitt, MD
DOAC does not prevent cognitive decline in adults with AF and a low risk of stroke
DOAC does not prevent cognitive decline in adults with AF and a low risk of stroke
Heart Matters
DOAC does not prevent cognitive decline in adults with AF and a low risk of stroke
- Léna Rivard, MD
Edoxaban as alternative to warfarin after bioprosthetic valve surgery
Edoxaban as alternative to warfarin after bioprosthetic valve surgery
Heart Matters
Edoxaban as alternative to warfarin after bioprosthetic valve surgery
- Chisato Izumi, MD, PhD
Audit and feedback strategy for pharmacists improves HF care
Audit and feedback strategy for pharmacists improves HF care
Heart Matters
Audit and feedback strategy for pharmacists improves HF care
- Alexander Sandhu, MD
HF Management for Patients with Comorbid Conditions
HF Management for Patients with Comorbid Conditions
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 program credits
- Neil Skolnik, MD
- Barry Greenberg, MD
- Karina Brown, BSN, RN
- Jessica Lin, MPAP
- Melissa Mclenon, DNP, ACNP-BC
0.75 program credits
MinuteCE®
Optimizing Heart Failure Management
0.75 credits 5 episodes
- Brian P. McDonough, MD, FAAFP
- Barry Greenberg, MD
- Neil Skolnik, MD
- Trina Huynh, PharmD
- Jessica Lin, MPAP
- Melissa Mclenon, DNP, ACNP-BC
- Karina Brown, BSN, RN
0.75 credits 5 episodes
A Practical Guide to Prescribing in HF
A Practical Guide to Prescribing in HF
MinuteCE®
A Practical Guide to Prescribing in HF
0.75 program credits
- Neil Skolnik, MD
- Barry Greenberg, MD
- Trina Huynh, PharmD
- Melissa Mclenon, DNP, ACNP-BC
0.75 program credits

Programs

Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Heart Matters
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
- Subodh Verma, MD, PhD
Acoramidis reduces all-cause mortality in ATTR-CM
Acoramidis reduces all-cause mortality in ATTR-CM
Heart Matters
Acoramidis reduces all-cause mortality in ATTR-CM
- Daniel Judge, MD
Effect of decision support system on early optimization of lipid-lowering therapy
Effect of decision support system on early optimization of lipid-lowering therapy
Heart Matters
Effect of decision support system on early optimization of lipid-lowering therapy
- Kausik Ray, MBChB, MD, MPhil
Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression
Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression
MinuteCE®
Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression
0.75 program credits
- Brian P. McDonough, MD, FAAFP
- Barry Greenberg, MD
- Neil Skolnik, MD
- Karina Brown, BSN, RN
0.75 program credits
Partnering with Patients: Building Effective Communication and Support in HF Care
Partnering with Patients: Building Effective Communication and Support in HF Care
MinuteCE®
Partnering with Patients: Building Effective Communication and Support in HF Care
0.75 program credits
- Brian P. McDonough, MD, FAAFP
- Barry Greenberg, MD
- Melissa Mclenon, DNP, ACNP-BC
0.75 program credits
How Artificial Sweeteners Could Be Linked to Heart Disease
How Artificial Sweeteners Could Be Linked to Heart Disease
Heart Matters
How Artificial Sweeteners Could Be Linked to Heart Disease
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Wilson Tang, MD
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
MinuteCE®
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
1.75 program credits
- Scott Kaatz, DO, MSc, FACP, SFHM
1.75 program credits
MinuteCE®
Primary Prevention, Initial Treatment & Management of VTE, Secondary VTE Prevention Strategies
1.75 credits 12 episodes
- Bruce L. Davidson, MD, MPH
- Scott Kaatz, DO, MSc, FACP, SFHM
- Deborah Siegal, MD, MSc, FRCPC
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
- Alfonso J. Tafur, MD, MS, MBA, RPVI
- Victor F. Tapson, MD
1.75 credits 12 episodes

Clinical Practice

New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
CME/CE
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
0.50 credits
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Scott Solomon, MD
- Mikhail Kosiborod, MD
0.50 credits
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Patient With VTE
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Patient With VTE
MinuteCE®
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Patient With VTE
1.75 program credits
- Bruce L. Davidson, MD, MPH
- Victor F. Tapson, MD
1.75 program credits
Case Time! VTE Prophylaxis Post Hip Replacement
Case Time! VTE Prophylaxis Post Hip Replacement
MinuteCE®
Case Time! VTE Prophylaxis Post Hip Replacement
1.75 program credits
- Victor F. Tapson, MD
1.75 program credits
Right from the Onset: PE Diagnosis, Management
Right from the Onset: PE Diagnosis, Management
MinuteCE®
Right from the Onset: PE Diagnosis, Management
1.75 program credits
- Bruce L. Davidson, MD, MPH
1.75 program credits
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
MinuteCE®
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
1.75 program credits
- Alfonso J. Tafur, MD, MS, MBA, RPVI
1.75 program credits
Right from the Onset: DVT Diagnosis, Management
Right from the Onset: DVT Diagnosis, Management
MinuteCE®
Right from the Onset: DVT Diagnosis, Management
1.75 program credits
- Bruce L. Davidson, MD, MPH
1.75 program credits
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
MinuteCE®
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
1.75 program credits
- Alfonso J. Tafur, MD, MS, MBA, RPVI
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
1.75 program credits
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
MinuteCE®
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
1.75 program credits
- Deborah Siegal, MD, MSc, FRCPC
1.75 program credits

CME

What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
MinuteCE®
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
1.75 program credits
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
1.75 program credits
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
MinuteCE®
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
1.75 program credits
- Deborah Siegal, MD, MSc, FRCPC
1.75 program credits
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
MinuteCE®
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
1.00 program credit
- Manesh R. Patel, MD
1.00 program credit
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
MinuteCE®
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
1.00 program credit
- Manesh R. Patel, MD
1.00 program credit
What Are the Latest Updates on the Clinical and Economic Impact of AF?
What Are the Latest Updates on the Clinical and Economic Impact of AF?
MinuteCE®
What Are the Latest Updates on the Clinical and Economic Impact of AF?
1.00 program credit
- Sean Pokorney, MD
1.00 program credit
Latest Guidance on Anticoagulation in Special AF Patient Populations
Latest Guidance on Anticoagulation in Special AF Patient Populations
MinuteCE®
Latest Guidance on Anticoagulation in Special AF Patient Populations
1.00 program credit
- Sean Pokorney, MD
1.00 program credit
AF Screening, Risk Factors, and Diagnosis: What’s New?
AF Screening, Risk Factors, and Diagnosis: What’s New?
MinuteCE®
AF Screening, Risk Factors, and Diagnosis: What’s New?
1.00 program credit
- Mina K. Chung, MD
1.00 program credit
Preventing Ischemic Stroke in Today’s World
Preventing Ischemic Stroke in Today’s World
MinuteCE®
Preventing Ischemic Stroke in Today’s World
1.50 program credits
- Mike Sharma, MD, MSc, FRCPC
1.50 program credits